Mithra Pharmaceuticals announced the appointment of Christophe Maréchal as Chief Financial Officer (CFO) with effect from February 23, 2017. Mr. Maréchal is currently Director, Group Treasury and Credit Risk Management, at Hamon Group. He has more than 20 years of financial experience in the international industrial, telecommunications, manufacturing and banking industries, including M&A, operational and financial strategy, and tactical initiatives to drive long-term business growth. Mr. Maréchal takes over from Steven Peters, who will support him during the transition period.